» Authors » M D Sitrin

M D Sitrin

Explore the profile of M D Sitrin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 740
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Berkelhammer C, Wood R, Sitrin M
JPEN J Parenter Enteral Nutr . 1998 May; 22(3):142-6. PMID: 9586791
Background: Increasing the inorganic phosphorus content of total parenteral nutrition (TPN) formulas has been shown to decrease TPN-induced hypercalciuria in experimental animals and humans. The mechanism of this effect, however,...
12.
Khare S, Bolt M, Wali R, Skarosi S, Roy H, Niedziela S, et al.
J Clin Invest . 1997 Apr; 99(8):1831-41. PMID: 9109427
Our laboratory has previously demonstrated that 1,25-dihydroxyvitamin D3 (1,25[OH]2D3) rapidly stimulated polyphosphoinositide (PI) hydrolysis, raised intracellular Ca2+, and activated two Ca2+-dependent protein kinase C (PKC) isoforms, PKC-alpha and -betaII in...
13.
Bothe A, Sitrin M
Nutr Clin Pract . 1996 Feb; 11(1):3-4. PMID: 8700060
No abstract available.
14.
Wali R, Frawley Jr B, Hartmann S, Roy H, Khare S, Earnest D, et al.
Cancer Res . 1995 Nov; 55(22):5257-64. PMID: 7585585
Several lines of evidence from our laboratory and others indicate that epigenetic alterations in protein kinase C (PKC) are involved in colonic carcinogenesis in both man and experimental animals. Furthermore,...
15.
Wali R, Bissonnette M, Khare S, Hart J, Sitrin M, Brasitus T
Cancer Res . 1995 Jul; 55(14):3050-4. PMID: 7606726
Vitamin D3 and its metabolites, particularly 1 alpha,25-dihydroxyvitamin D3 (1 alpha, 25(OH)2D3), have received increasing attention as potential anticarcinogens in the prevention of cancers in a number of organs, including...
16.
Bissonnette M, Wali R, Hartmann S, Niedziela S, Roy H, Tien X, et al.
J Clin Invest . 1995 May; 95(5):2215-21. PMID: 7738187
Considerable evidence that alterations in protein kinase C (PKC) are intimately involved in important physiologic and pathologic processes in many cells, including colonic epithelial cells, has accumulated. In this regard,...
17.
Wali R, Bissonnette M, Jiang K, Niedziela S, Khare S, Roy H, et al.
J Cell Physiol . 1995 Feb; 162(2):172-80. PMID: 7822428
Our laboratory has recently demonstrated that 1,25-dihydroxyvitamin D3(1,25(OH)2D3) rapidly stimulated membrane polyphosphoinositide breakdown and increased intracellular calcium, as well as activated protein kinase C (PKC) in vitamin D-sufficient rat colonocytes....
18.
Khare S, Wilson D, Wali R, Tien X, Bissonnette M, Niedziela S, et al.
Biochem Biophys Res Commun . 1994 Sep; 203(3):1432-7. PMID: 7945291
The polypeptide guanylin is an endogenous activator of small intestinal guanylate cyclase. In rat, guanylin mRNA is found predominantly in intestinal tissues, with its highest abundance in the colon. To...
19.
Bissonnette M, Tien X, Niedziela S, Hartmann S, Frawley Jr B, Roy H, et al.
Am J Physiol . 1994 Sep; 267(3 Pt 1):G465-75. PMID: 7943245
Our laboratory recently reported that 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] rapidly increases the breakdown of membrane phosphoinositides, raises intracellular calcium concentration ([Ca2+]i), and translocates protein kinase C (PKC) from the cytosolic to...
20.
Khare S, Tien X, Wilson D, Wali R, Bissonnette B, Sitrin M, et al.
Endocrinology . 1994 Jul; 135(1):277-83. PMID: 7912183
Recent studies have implicated protein kinase-C (PKC) in the regulation of guanylate cyclase in several cell types. In view of prior experiments by our laboratory which have demonstrated that 1...